Pharmacokinetic-Pharmacodynamic Modeling of the Antitumor Effects of SGN-CD19A, a Novel Antibody-Drug Conjugate, in Mice

被引：0
|
作者：
Zhao, Baiteng [1 ]
Stevison, Faith [1 ]
Law, Che-Leung [2 ]
Han, Tae H. [1 ]
机构：
[1] Seattle Genet Inc, Clin Pharmacol, Bothell, WA 98021 USA
[2] Seattle Genet Inc, Preclin Res, Bothell, WA 98021 USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2013年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S17 / S18
页数：2
相关论文
共 50 条
  • [41] An anti-CD103 antibody-drug conjugate prolongs the survival of pancreatic islet allografts in mice
    Da Xue
    Pili Liu
    Wangming Chen
    Chi Zhang
    Lei Zhang
    Cell Death & Disease, 10
  • [42] An anti-CD103 antibody-drug conjugate prolongs the survival of pancreatic islet allografts in mice
    Xue, Da
    Liu, Pili
    Chen, Wangming
    Zhang, Chi
    Zhang, Lei
    CELL DEATH & DISEASE, 2019, 10 (10)
  • [43] Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug Conjugate (vol 16, pg 888, 2010)
    Okeley, N. M.
    Miyamoto, J. B.
    Zhang, X.
    Sanderson, R. J.
    Benjamin, D. R.
    Sievers, E. L.
    CLINICAL CANCER RESEARCH, 2011, 17 (16) : 5524 - 5524
  • [44] Development of a novel antibody-drug conjugate targeting endosialin/TEM-1: potent antitumor activity in sarcoma
    Sala, Gianluca
    Iacobelli, Stefano
    Capone, Emily
    PIccolo, Enza
    Sauniere, Jean-Fred
    Douet, Vanessa Vannucci
    CANCER RESEARCH, 2017, 77
  • [45] Pharmacokinetic-pharmacodynamic modeling of the antitumor effect of TM208 and EGFR-TKI resistance in human breast cancer xenograft mice
    Ji, Xi-wei
    Ji, Shuang-min
    Li, Run-tao
    Wu, Ke-hua
    Zhu, Xiao
    Lu, Wei
    Zhou, Tian-yan
    ACTA PHARMACOLOGICA SINICA, 2016, 37 (06) : 825 - 833
  • [46] Potent antitumor activity of the anti-CD19 auristatin antibody-drug conjugate hBU12-vcMMAE in rituximab sensitive and resistant lymphomas
    Gerber, H. P.
    Stone, I.
    Kung-Sutherland, M.
    Miyamoto, J.
    Okeley, N.
    Alley, S. C.
    Meyer, D. L.
    Sussman, D.
    Senter, P.
    Grewal, I. S.
    EJC SUPPLEMENTS, 2008, 6 (12): : 161 - 161
  • [47] Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody-Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function
    Jin, Rui
    Liu, Liang
    Xing, Yun
    Meng, Tao
    Ma, Lanping
    Pei, Jinpeng
    Cong, Ying
    Zhang, Xuesai
    Ren, Zhiqiang
    Wang, Xin
    Shen, Jingkang
    Yu, Ker
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (11) : 2340 - 2352
  • [48] Pharmacokinetic-pharmacodynamic modeling of the antitumor effect of TM208 and EGFR-TKI resistance in human breast cancer xenograft mice
    Xi-wei Ji
    Shuang-min Ji
    Run-tao Li
    Ke-hua Wu
    Xiao Zhu
    Wei Lu
    Tian-yan Zhou
    Acta Pharmacologica Sinica, 2016, 37 : 825 - 833
  • [49] Effects of idiotypic human anti-mouse antibody against in vitro binding and antitumor activity of a monoclonal antibody-drug conjugate
    Otsuji, E
    Tsuruta, H
    Toma, A
    Kobayashi, S
    Okamoto, K
    Yata, Y
    Yamagishi, H
    HEPATO-GASTROENTEROLOGY, 2003, 50 (50) : 380 - 384
  • [50] SGN-PDL1V, A NOVEL, INVESTIGATIONAL PD-L1-DIRECTED ANTIBODY-DRUG CONJUGATE FOR THE TREATMENT OF SOLID TUMORS
    Kwan, Byron
    Ramirez, Megan
    Jin, Steven
    Yu, Changpu
    Wo, Serena
    Gupta, Priyanka
    Allred, Sean
    Simmons, Jessica
    Hensley, Kelly
    de Zafra, Christina Zuch
    Neff-LaFord, Haley
    Hengel, Shawna
    Forero-Torres, Andres
    Van Epps, Heather
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A818 - A818
12345